Log In
Print
BCIQ
Print
Print this Print this
 

2B3-101

  Manage Alerts
Collapse Summary General Information
Company BBB Therapeutics B.V.
DescriptionPegylated liposomal doxorubicin conjugated with glutathione
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat brain metastases and primary brain tumors; Treat glioma
Regulatory Designation

U.S. - Orphan Drug (Treat glioma);
EU - Orphan Drug (Treat glioma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today